Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lode Dewulf

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Therapeutic Innovation & Regulatory Science|September 18, 2018
Patient Engagement by Pharma-Why and How? A Framework for Compliant Patient EngagementLode Dewulf
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 3, 2016
Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG) : The use of medicines during pregnancy: call for actionKristel Van Calsteren, Ksenija Gersak, Hildrun Sundseth, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 3, 2016
Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy - call for actionKristel Van Calsteren, Ksenija Gersak, Hildrun Sundseth, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Medicines in Pregnancy Forum: Proceedings on Ethical and Legal ConsiderationsDavid B Clemow, Martha R Nolan, Debra L Michaels, et al.
Therapeutic Innovation & Regulatory Science|September 24, 2023
Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: A Global Landscape ReviewNeil Bertelsen, Lode Dewulf, Silvia Ferrè, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Clinical Data for Informed Medication Use in Pregnancy: Strengths, Limitations, Gaps, and a Need to Continue Moving ForwardDavid B Clemow, Lode Dewulf, Gideon Koren, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
A Proposed Framework to Address Needs of Clinical Data for Informed Medication Use in PregnancyDavid B Clemow, Lode Dewulf, Debra L Michaels, et al.
The Journal of Rheumatology|May 19, 2009
Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcomeAnnelies Boonen, Bert vander Cruyssen, Kurt de Vlam, et al.
Annals of the Rheumatic Diseases|January 31, 2007
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practiceBert Vander Cruyssen, Clio Ribbens, Annelies Boonen, et al.
Therapeutic Innovation & Regulatory Science|February 25, 2017
Culture and Process Change as a Priority for Patient Engagement in Medicines DevelopmentMarc Boutin, Lode Dewulf, Anton Hoos, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|September 18, 2018
Patient Engagement by Pharma-Why and How? A Framework for Compliant Patient EngagementLode Dewulf
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 3, 2016
Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG) : The use of medicines during pregnancy: call for actionKristel Van Calsteren, Ksenija Gersak, Hildrun Sundseth, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 3, 2016
Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy - call for actionKristel Van Calsteren, Ksenija Gersak, Hildrun Sundseth, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Medicines in Pregnancy Forum: Proceedings on Ethical and Legal ConsiderationsDavid B Clemow, Martha R Nolan, Debra L Michaels, et al.
Therapeutic Innovation & Regulatory Science|September 24, 2023
Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: A Global Landscape ReviewNeil Bertelsen, Lode Dewulf, Silvia Ferrè, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Clinical Data for Informed Medication Use in Pregnancy: Strengths, Limitations, Gaps, and a Need to Continue Moving ForwardDavid B Clemow, Lode Dewulf, Gideon Koren, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
A Proposed Framework to Address Needs of Clinical Data for Informed Medication Use in PregnancyDavid B Clemow, Lode Dewulf, Debra L Michaels, et al.
The Journal of Rheumatology|May 19, 2009
Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcomeAnnelies Boonen, Bert vander Cruyssen, Kurt de Vlam, et al.
Annals of the Rheumatic Diseases|January 31, 2007
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practiceBert Vander Cruyssen, Clio Ribbens, Annelies Boonen, et al.
Therapeutic Innovation & Regulatory Science|February 25, 2017
Culture and Process Change as a Priority for Patient Engagement in Medicines DevelopmentMarc Boutin, Lode Dewulf, Anton Hoos, et al.
Pageof 2